Sam-A to patent a composite process of Carmodix suspension tablet.

Published: 2005-09-26 06:57:00

Updated: 2005-09-26 06:57:00

Sam-A Pharm. Co. announced on Sept. 21 that the manufacturing process and the composite of Carmodix suspension tablet, a combined penicillin antibiotic of AMX/CLA made patent registration (Pat. Reg. No. 0515311) in Korea.

The company explained the patent covering the manufacturing process and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK